His U.S. medical career started when he was recruited to UCLA, where he was a well published researcher, a groundbreaking transplant surgeon, and most importantly, inventor of Abraxane, a cancer fighting drug. Forbes reported his net worth at around $9 billion, making him #45 on their September 2013 400 Richest Americans list.